The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Open accessAbstract
BACKGROUND: In observational studies, lower homocysteine levels are associated with lower rates of coronary heart disease and stroke. Folic acid and vitamins B6 and B12 lower homocysteine levels. We assessed whether supplementation reduced the risk of major cardiovascular events in patients with vascular disease. METHODS: We randomly assigned 5522 patients 55 years of age or older who had vascular disease or diabetes to daily treatment either with the combination of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12 or with placebo for an average of five years. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, and stroke. RESULTS: Mean plasma homocysteine levels decreased by 2.4 micromol per liter (0.3 mg per liter) in the active-treatment group and increased by 0.8 micromol per liter (0.1 mg per liter) in the placebo group. Primary outcome events occurred in 519 patients (18.8 percent) assigned to active therapy and 547 (19.8 percent) assigned to placebo (relative risk, 0.95; 95 percent confidence interval, 0.84 to 1.07; P=0.41). As compared with placebo, active treatment did not significantly decrease the risk of death from cardiovascular causes (relative risk, 0.96; 95 percent confidence interval, 0.81 to 1.13), myocardial infarction (relative risk, 0.98; 95 percent confidence interval, 0.85 to 1.14), or any of the secondary outcomes. Fewer patients assigned to active treatment than to placebo had a stroke (relative risk, 0.75; 95 percent confidence interval, 0.59 to 0.97). More patients in the active-treatment group were hospitalized for unstable angina (relative risk, 1.24; 95 percent confidence interval, 1.04 to 1.49). CONCLUSIONS: Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current Controlled Trials number, ISRCTN14017017.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,708
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,945
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease
Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., & Schouten, E. G. (2002) · JAMA · doi:10.1001/jama.288.16.2023 · Cited by 932
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
Horigan, G., McNulty, H., Ward, M., Strain, J., Purvis, J., & Scott, J. M. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328334c126 · Cited by 122
Sattar, N. A., Crompton, P., Cherry, L., Kane, D., Lowe, G. D. O., & McInnes, I. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22447 · Cited by 118
Chawla, J. P. S., & Kvarnberg, D. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00059-0 · Cited by 119
Toms, T. E., Panoulas, V. F., John, H., Douglas, K., & Kitas, G. D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2765 · Cited by 119
Chwatko, G., Boers, G. H. J., Strauss, K. A., Shih, D. M., & Jakubowski, H. (2007) · The FASEB Journal · doi:10.1096/fj.06-7435com · Cited by 119
Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
Faeh, D., Chioléro, A., & Paccaud, F. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11283 · Cited by 120
Obersby, D., Chappell, D. C., Dunnett, A., & Tsiami, A. A. (2013) · British Journal Of Nutrition · doi:10.1017/s000711451200520x · Cited by 117
Vitamin D and Cardiovascular Disease
Nemerovski, C. W., Dorsch, M. P., Simpson, R. U., Bone, H. G., Aaronson, K. D., & Bleske, B. E. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.691 · Cited by 118
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. A., Friday, G. H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820d8c98 · Cited by 119
Too much folate: a risk factor for cancer and cardiovascular disease?
Sauer, J., Mason, J. B., & Choi, S. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831cec62 · Cited by 116
Epigenetic modifications and human pathologies: cancer and CVD
Duthie, S. J. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110003952 · Cited by 117
Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Dayal, S., & Lentz, S. R. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.166421 · Cited by 116
Hirschowitz, B. I., Worthington, J. L., & Mohnen, J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03658.x · Cited by 115
Heinz, J., Kropf, S., Luley, C. H., & Dierkes, J. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.266 · Cited by 114
Homocysteine metabolism and its relation to health and disease
Williams, K. T., & Schalinske, K. L. (2010) · BioFactors · doi:10.1002/biof.71 · Cited by 115
Jellinger, P. S., Smith, D. A., Mehta, A., Ganda, O. P., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., Seibel, J. A., Kreisberg, R. A., & Goldberg, R. B. (2012) · Endocrine Practice · doi:10.4158/ep.18.2.269 · Cited by 113
Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs
Pogue, J. M., Walter, S. D., & Yusuf, S. (2009) · Clinical Trials · doi:10.1177/1740774509105223 · Cited by 113
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., & Lathyris, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub4 · Cited by 113
Miller, E. R., Juraschek, S., Pastor-Barriuso, R., Bazzano, L. A., Appel, L. J., & Guallar, E. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.064 · Cited by 112
Wang, Y., Zhang, S., Zhang, L., & Wang, C. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00290.x · Cited by 113
B vitamins and the aging brain
Selhub, J., Troen, A. M., & Rosenberg, I. H. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00346.x · Cited by 111
Ford, A. H., & Almeida, O. P. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00649-w · Cited by 113
Vitamin B6: a challenging link between nutrition and inflammation in CVD
Lotto, V., Choi, S., & Friso, S. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511000407 · Cited by 114
Inherited Thrombophilias and Adverse Pregnancy Outcomes
Davenport, W. B., & Kutteh, W. H. (2013) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.10.005 · Cited by 111
Jardine, M., Kang, A., Zoungas, S., Navaneethan, S. D., Ninomiya, T., Nigwekar, S. U., Gallagher, M., Cass, A., Strippoli, G. F., & Perkovic, V. (2012) · BMJ · doi:10.1136/bmj.e3533 · Cited by 112
Gupta, S., Kühnisch, J., Mustafa, A., Lhoták, Š., Schlachterman, A., Slifker, M. J., Klein–Szanto, A. J., High, K. A., Austin, R. C., & Kruger, W. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-120584 · Cited by 111
B‐vitamins reduce the long‐term risk of depression after stroke: The VITATOPS‐DEP trial
Almeida, O. P., Marsh, K., Alfonso, H. S., Flicker, L. A., Davis, T. M. E., & Hankey, G. J. (2010) · Annals of Neurology · doi:10.1002/ana.22189 · Cited by 110
Hyperhomocysteinemia: Clinical Insights
Mutairi, F. A. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573520962230 · Cited by 117
Sato, D., & Nozaki, T. (2009) · IUBMB Life · doi:10.1002/iub.255 · Cited by 113
Chen, H., Wang, Y., Chang, J. Y., Wu, Y., Cheng, S., & Sun, A. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2014.10.004 · Cited by 109
Nutrition and the risk of stroke
Hankey, G. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70265-4 · Cited by 111
Hao, L., Ma, J., Zhu, J., Stampfer, M. J., Tian, Y., Willett, W. C., & Li, Z. (2007) · Journal of Nutrition · doi:10.1093/jn/137.2.407 · Cited by 108
Beard, R. S., & Bearden, S. E. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00598.2010 · Cited by 109
Folic acid supplementation and cancer risk: A meta‐analysis of randomized controlled trials
Qin, X., Cui, Y., Shen, L., Sun, N., Zhang, Y., Li, J., Xu, X. P., Wang, B., Xu, X., Huo, Y., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28038 · Cited by 106
Yang, H.-T., Lee, M., Hong, K., Ovbiagele, B. I., & Saver, J. L. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.07.004 · Cited by 106
Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus
Martini, L. A., Catania, A. S., & Ferreira, S. R. G. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00296.x · Cited by 105
Moazzen, S., Dolatkhah, R., Tabrizi, J. S., Shaarbafi, J., Alizadeh, B. Z., de Bock, G. H., & Dastgiri, S. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.10.010 · Cited by 109
SEARCH Study Collaborative Group (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.034 · Cited by 110
Gao, L., Chalupský, K., Stefani, E., & Cai, H. “. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.025 · Cited by 105
Association of Cardiovascular Risk Factors and Disease With Depression in Later Life
Almeida, O. P., Flicker, L. A., Norman, P. E., Hankey, G. J., Vasikaran, S. D., BOCKXMEER, F. M. V., & Jamrozik, K. D. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000246869.49892.77 · Cited by 103
Homocysteine and vascular disease: review of published results of the homocysteine‐lowering trials
Clarke, R., Halsey, J., Bennett, D., & Lewington, S. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9235-y · Cited by 104
Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration
Gopinath, B., Flood, V. M., Rochtchina, E., Wang, J. J., & Mitchell, P. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.057091 · Cited by 108
“Christen et al (4) hypothesized that a direct antioxidant effect of vitamin B-12 and folate and enhancement of endothelial nitric oxide concentrations in the choroidal vasculature with an associated increase in vascular reactivity (48) could underlie the beneficial effects of vitamin B-12 and folic acid supplements on…”
BackgroundNutrition and Stroke Prevention
Fisher, M., Lees, K. R., & Spence, J. D. (2006) · Stroke · doi:10.1161/01.str.0000236633.40160.ee · Cited by 102
The Role of Homocysteine‐Lowering B‐Vitamins in the Primary Prevention of Cardiovascular Disease
Debreceni, B., & Debreceni, L. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12064 · Cited by 116
Hoey, L., McNulty, H., Askin, N., Dunne, A., Ward, M., Pentieva, K. D., Strain, J., Molloy, A. M., Flynn, C. A., & Scott, J. M. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1405 · Cited by 100
Li, Z., Ye, R., Zhang, L., Li, H., Liu, J., & Ren, A. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00230 · Cited by 102
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs
Belcastro, V., Striano, P., Gorgone, G., Costa, C., Ciampa, C., Caccamo, D., Pisani, L. R., Oteri, G., Marciani, M. G., Aguglia, U., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02303.x · Cited by 101
A Multi-Marker Approach to Predict Incident CKD and Microalbuminuria
Fox, C. S., Gona, P. N., Larson, M. G., Selhub, J., Tofler, G. H., Hwang, S., Meigs, J. B., Levy, D. A., Wang, T. J., Jacques, P. F., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010085 · Cited by 102
Primary prevention of stroke: blood pressure, lipids, and heart failure
Endres, M., Heuschmann, P. U., Laufs, U., & Hakim, A. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq472 · Cited by 107
The molecular basis of homocysteine thiolactone-mediated vascular disease
Jakubowski, H. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.338 · Cited by 99
“These findings also suggest that while primary Hcy-lowering intervention by vitamin supplementation is beneficial, secondary intervention may be ineffective, and may explain at least in part the failure of vitamin therapy (11, 12) to lower cardiovascular events in myocardial infarction patients.”
BackgroundHo, R. C. M., Cheung, M. W. L., Fu, E., Win, H. H., Zaw, M. H., Ng, A., & Mak, A. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181f17eed · Cited by 99
Interpreting Geographic Variations in Results of Randomized, Controlled Trials
Yusuf, S., & Wittes, J. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510065 · Cited by 99
Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging
McCully, K. S. (2015) · Comprehensive physiology · doi:10.1002/cphy.c150021 · Cited by 109
Cianciolo, G., Pascalis, A. D., Lullo, L. D., Ronco, C., Zannini, C., & Manna, G. L. (2017) · Cardiorenal Medicine · doi:10.1159/000471813 · Cited by 97
Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease
Jakubowski, H., & Witucki, Ł. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020746 · Cited by 113
Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy
Zhang, Y., Janssens, S. P., Wingler, K., Schmidt, H. H. H. W., & Moens, A. L. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01315.2010 · Cited by 99
Kim, C., Kim, Y., Naqvi, A., Kumar, S., Hoffman, T. A., Jung, S.-B., Kumar, A., Jeon, B. H., McNamara, D. M., & Irani, K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr250 · Cited by 96
Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons
Mason, J. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00190.x · Cited by 97
Lin, H., Wang, Y., Chen, H., Kuo, Y., Lang, M.-J., & Sun, A. (2012) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2012.02.022 · Cited by 94
Homocysteine levels and leukocyte telomere length
Richards, J. B., Valdes, A. M., Gardner, J. P., Kato, B. S., Siva, A., Kimura, M., Lu, X., Brown, M. J., Aviv, A., & Spector, T. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.035 · Cited by 95
Mann, J. F. E., Sheridan, P., McQueen, M., Held, C., Arnold, J. M. O., Fodor, G. J., Yusuf, S., Lonn, E., & on behalf of the HOPE-2 investigators (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm485 · Cited by 94
Protocol biopsies in renal transplantation: Prognostic value of structural monitoring
Serón, D., & Moreso, F. (2007) · Kidney International · doi:10.1038/sj.ki.5002396 · Cited by 93
Krishna, S. M., Dear, A. E., Craig, J. M., Norman, P. E., & Golledge, J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.019 · Cited by 92
Polyamine Metabolism and Gene Methylation in Conjunction with One-Carbon Metabolism
Soda, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103106 · Cited by 95
Folic Acid Supplementation Promotes Mammary Tumor Progression in a Rat Model
Manshadi, S. D., Ishiguro, L., Sohn, K., Medline, A., Renlund, R., Croxford, R., & Kim, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084635 · Cited by 90
Cacciapuoti, F. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0550-4 · Cited by 92
Water‐Soluble Vitamins in People with Low Glomerular Filtration Rate or On Dialysis: A Review
Clase, C. M., Ki, V., & Holden, R. M. (2013) · Seminars in Dialysis · doi:10.1111/sdi.12099 · Cited by 96
Yang, J., Fang, P., Yu, D., Zhang, L., Zhang, D., Jiang, X., Yang, W. Y., Bottiglieri, T., Kunapuli, S. P., Yu, J. G., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308750 · Cited by 93
A Clinician’s Guide for Trending Cardiovascular Nutrition Controversies
Freeman, A. M., Morris, P. B., Aspry, K. E., Gordon, N. F., Barnard, N. D., Esselstyn, C. B., Ros, E., Devries, S. R., O’Keefe, J. H., Miller, M. J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.030 · Cited by 93
“The HOPE 2 (Heart Outcomes Prevention Evaluation) trial found that daily treatment with folic acid, vitamin B6, and vitamin B12 for an average of 5 years reduced homocysteine levels and the risk of stroke, but not the risk of major CV events; moreover, a greater number of patients receiving active treatment were hospi…”
BackgroundDietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study
Harriss, L. R., English, D. R., Powles, J. W., Giles, G. G., Tonkin, A. M., Hodge, A. M., Brazionis, L., & O’Dea, K. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.221 · Cited by 93
Folic Acid Fortification and Supplementation-Good for Some but Not So Good for Others
Kim, Y. (2007) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00275.x · Cited by 105
Biomarker for Ischemic Stroke Using Metabolome: A Clinician Perspective
Sidorov, E., Sanghera, D. K., & Vanamala, J. K. P. (2019) · Journal of Stroke · doi:10.5853/jos.2018.03454 · Cited by 89
“Elevated total homocysteine levels induce oxidative stress to vascular endothelial cells and impair production of nitric oxide, a strong vascular relaxing factor in the endothelium.44,45 Homocysteine enhances platelets adhesions to vessel walls, which is better described in lacunar infarctions.23 Increased levels of h…”
BackgroundMethodInfluentialHomocysteine and diabetes: Role in macrovascular and microvascular complications
Muzurović, E. M., Kraljević, I., Solak, M., Dragnić, S., & Mikhailidis, D. P. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107834 · Cited by 89
Towfighi, A., Markovic, D., & Ovbiagele, B. I. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.07.013 · Cited by 91
Muennig, P. A., Sohler, N., & Mahato, B. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.04.005 · Cited by 89
Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis
Huo, Y., Qin, X., Wang, J., Sun, N., Zeng, Q., Xu, X., Liu, L., Xu, X., & Wang, X. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02929.x · Cited by 88
Sun, A., Lin, H., Wang, Y., Chen, H., Cheng, S., & Chiang, C. (2013) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12043 · Cited by 88
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Nouh, A. M., Hussain, M., Mehta, T., & Yaghi, S. R. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00037 · Cited by 89
Update on the NCEP ATP-III emerging cardiometabolic risk factors
Eckel, R. H., & Cornier, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-115 · Cited by 96
Hajer, G. R., van der Graaf, Y., Olijhoek, J. K., Verhaar, M. C., Visseren, F. L. J., & for the SMART Study Group (2005) · Heart · doi:10.1136/hrt.2006.093971 · Cited by 88
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., Karakitsiou, D.-E., & Simancas‐Racines, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub3 · Cited by 87
Folic acid in general medicine and dermatology
Gisondi, P., Fantuzzi, F., Malerba, M., & Girolomoni, G. (2007) · Journal of Dermatological Treatment · doi:10.1080/09546630701247930 · Cited by 85
Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
Norwitz, N. G., Saif, N., Ariza, I. E., & Isaacson, R. (2021) · Nutrients · doi:10.3390/nu13041362 · Cited by 92
Roberts, M. A., Hare, D. L., Ratnaike, S., & Ierino, F. L. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.06.005 · Cited by 86
Hyperhomocysteinemia, DNA methylation and vascular disease
Jamaluddin, M. S., Yang, X., & Wang, H. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.350 · Cited by 85
Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism
Xiao, Y., Su, X., Huang, W. H., Zhang, J., Peng, C., Huang, H., Wu, X., Huang, H., Xia, M., & Ling, W. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.015 · Cited by 85
Yusuf, S., Pais, P. S., Sigamani, A., Xavier, D., Afzal, R., Gao, P., & Teo, K. K. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.963637 · Cited by 83
Prajapat, M., Shekhar, N., Sarma, P., Avti, P., Singh, S. K., Kaur, H., Bhattacharyya, A., Kumar, S., Sharma, S., Prakash, A., et al. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107716 · Cited by 88
Abraham, J. M., & Cho, L. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10036 · Cited by 83
Vascular dementia: From pathobiology to emerging perspectives
Morgan, A. E., & Auley, M. T. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102278 · Cited by 102
Kwok, T. C. Y., Lee, J.-H., Law, C. B., Pan, P. C., Yung, C. Y., Choi, K. C., & LAM, L. C. W. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2010.12.004 · Cited by 83
Johansson, I., Guelpen, B. R. V., Hultdin, J., Johansson, M., Hallmans, G., & Stattin, P. E. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.80 · Cited by 84
Stroke: roles of B vitamins, homocysteine and antioxidants
Sánchez‐Moreno, C., Jiménez‐Escrig, A., & Martin-Marco, A. (2009) · Nutrition Research Reviews · doi:10.1017/s0954422409990023 · Cited by 83
Zhou, Y.-H., Tang, J.-Y., Wu, M.-J., Lu, J., Wei, X., Qin, Y.-Y., Wang, C., Xu, J., & He, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025142 · Cited by 83
Traffic-related Particles Are Associated with Elevated Homocysteine
Park, S. K., O’Neill, M. S., Vokonas, P., Sparrow, D., Spiro, A., Tucker, K. L., Suh, H. H., Hu, H., & Schwartz, J. D. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1286oc · Cited by 82
Kuo, H.-K., Liao, K., Leveille, S. G., Bean, J. F., Yen, C., Chen, J.-H., Yu, Y., & Tai, T. Y. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.4.434 · Cited by 81
“Although homocysteine-lowering therapy with B vitamins has not been shown to have cardiovascular benefits (29,30), clinical Table 4.”
BackgroundRecent Advances in Preventive Cardiology and Lifestyle Medicine
Franklin, B. A., & Cushman, M. (2011) · Circulation · doi:10.1161/circulationaha.110.981613 · Cited by 82
Homocysteine and arterial thrombosis: Challenge and opportunity
Tremoli, E., Coppola, A., Lupoli, R., Minno, G. D., & Minno, M. N. D. D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-06-0393 · Cited by 82
Midttun, Ø., Ulvik, A., Pedersen, E. R., Ebbing, M., Bleie, Ø., Schartum-Hansen, H., Nilsen, R. M., Nygard, O. K., & Ueland, P. M. (2011) · Journal of Nutrition · doi:10.3945/jn.110.133082 · Cited by 80
Role of folate in nonalcoholic fatty liver disease
Sid, V., Siow, Y. L., & Karmin, O. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0681 · Cited by 82
“Although folic acid supplementation could effectively reduce homocysteine levels in the circulation (Boushey et al. 1995; Lonn et al. 2006), cardiovascular risk was not improved in patients with vascular disease (Lonn et al. 2006).”
Background
Metadata
- Authors
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Affiliations
- Hamilton General Hospital (CA)
- Corresponding author
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-13
- Volume
- 354
- Issue
- 15
- Pages
- 1567-1577
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109544293
- Cited by
- 1,729
- References
- 20
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 33 · 2023: 30 · 2022: 43 · 2021: 37 · 2020: 52 · 2019: 46 · 2018: 46 · 2017: 70 · 2016: 81 · 2015: 77 · 2014: 84 · 2013: 85 · 2012: 104
- FWCI
- 136.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Massachusetts Medical Society
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- homocysteine lowering, folic acid, vitamin B6, vitamin B12, vascular disease, cardiovascular events, stroke, myocardial infarction, cardiovascular mortality, unstable angina, diabetes mellitus, older adults
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Vascular Diseases, Vitamin B 12, Hyperhomocysteinemia, Stroke, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
